These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 36768582)
21. PURA syndrome in a child with severe developmental delay: a challenging diagnosis. Nogueira M; Melo C; Grangeia A; Magalhães T; Soares C; Dias R; Fonseca J; Sampaio M; Sousa R Rev Neurol; 2022 Mar; 74(5):170-173. PubMed ID: 35211951 [TBL] [Abstract][Full Text] [Related]
22. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome. Al-Muhaizea MA; AlQuait L; AlRasheed A; AlHarbi S; Albader AA; AlMass R; Albakheet A; Alhumaidan A; AlRasheed MM; Colak D; Kaya N Neuromuscul Disord; 2020 Jul; 30(7):611-615. PubMed ID: 32616363 [TBL] [Abstract][Full Text] [Related]
35. De novo mutations in PURA are associated with hypotonia and developmental delay. Tanaka AJ; Bai R; Cho MT; Anyane-Yeboa K; Ahimaz P; Wilson AL; Kendall F; Hay B; Moss T; Nardini M; Bauer M; Retterer K; Juusola J; Chung WK Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000356. PubMed ID: 27148565 [TBL] [Abstract][Full Text] [Related]
36. Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment. McMacken G; Whittaker RG; Wake R; Lochmuller H; Horvath R J Neurol; 2023 Jun; 270(6):3112-3119. PubMed ID: 36869887 [TBL] [Abstract][Full Text] [Related]
37. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662 [TBL] [Abstract][Full Text] [Related]
39. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review. Yıldırım M; Yarenci GB; Genç MB; Uçar Çİ; Bayav S; Tekin MN; Bektaş Ö; Teber S Neuropediatrics; 2024 Jun; 55(3):200-204. PubMed ID: 38531369 [TBL] [Abstract][Full Text] [Related]
40. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia. Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]